Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
51.40
+0.25 (0.49%)
At close: Dec 20, 2024, 4:00 PM
52.55
+1.15 (2.24%)
After-hours: Dec 20, 2024, 4:24 PM EST

Corcept Therapeutics Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for CORT stock have an average target of 75.25, with a low estimate of 67 and a high estimate of 80. The average target predicts an increase of 46.40% from the current stock price of 51.40.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $67 $75.25 $78 $80
Change +30.35% +46.40% +51.75% +55.64%
* Price targets were last updated on Oct 31, 2024.

Analyst Ratings

The average analyst rating for CORT stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jul '24Aug '24Sep '24Oct '24Nov '24Dec '24
Strong Buy 333333
Buy 111111
Hold 110000
Sell 000000
Strong Sell 000000
Total 554444

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$80
Strong Buy Reiterates $80 +55.64% Oct 31, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$45$80
Strong Buy Maintains $45$80 +55.64% Oct 18, 2024
Truist Securities
Truist Securities
Strong Buy
Maintains
$65$76
Strong Buy Maintains $65$76 +47.86% Sep 30, 2024
Piper Sandler
Piper Sandler
Buy
Maintains
$38$67
Buy Maintains $38$67 +30.35% Sep 18, 2024
Canaccord Genuity
Canaccord Genuity
Strong Buy
Maintains
$38$78
Strong Buy Maintains $38$78 +51.75% Jul 31, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
705.67M
from 482.38M
Increased by 46.29%
Revenue Next Year
826.28M
from 705.67M
Increased by 17.09%
EPS This Year
1.39
from 0.94
Increased by 47.57%
EPS Next Year
1.79
from 1.39
Increased by 28.77%
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
306.49M353.87M365.98M401.86M482.38M705.67M826.28M1.14B
Revenue Growth
21.99%15.46%3.42%9.80%20.04%46.29%17.09%37.97%
EPS
0.770.850.890.870.941.391.793.80
EPS Growth
28.33%10.39%4.71%-2.25%8.05%47.57%28.77%112.85%
Forward PE
-----37.0528.7713.52
No. Analysts -----776
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026202720282029
High 735.6M 920.2M 1.5B
Avg 705.7M 826.3M 1.1B
Low 672.3M 744.7M 896.7M

Revenue Growth

Revenue Growth 202420252026202720282029
High
52.5%
30.4%
83.4%
Avg
46.3%
17.1%
38.0%
Low
39.4%
5.5%
8.5%

EPS Forecast

EPS 202420252026202720282029
High 1.51 2.10 5.57
Avg 1.39 1.79 3.80
Low 1.27 1.33 2.34

EPS Growth

EPS Growth 202420252026202720282029
High
60.9%
51.4%
211.5%
Avg
47.6%
28.8%
112.8%
Low
35.5%
-3.9%
31.1%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.